15.49% to Target, Berenberg Bank Reconfirms Buy Rating for Spire Healthcare Group (LON:SPI) Stock, 4 Analysts Are Bullish Gem Diamonds Limited (LON:GEMD) Last Week

June 21, 2017 - By wolcottdaily

Among 13 analysts covering Gem Diamonds Ltd (LON:GEMD), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Gem Diamonds Ltd had 109 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Sector Performer” rating in Monday, February 13 report. The company was maintained on Friday, April 21 by Barclays Capital. FinnCap maintained the shares of GEMD in report on Tuesday, August 4 with “Buy” rating. The rating was maintained by Barclays Capital on Thursday, November 12 with “Overweight”. The stock has “Neutral” rating by JP Morgan on Wednesday, April 19. On Monday, June 5 the stock rating was maintained by JP Morgan with “Neutral”. As per Friday, September 25, the company rating was maintained by Liberum Capital. The firm has “Buy” rating by Liberum Capital given on Monday, July 27. The stock of Gem Diamonds Limited (LON:GEMD) has “Outperform” rating given on Monday, November 16 by Macquarie Research. The firm has “Market Perform” rating by BMO Capital Markets given on Wednesday, February 3. See Gem Diamonds Limited (LON:GEMD) latest ratings:

12/06/2017 Broker: Liberum Capital Rating: Hold Old Target: GBX 90.00 New Target: GBX 90.00 Maintain
09/06/2017 Broker: RBC Capital Markets Rating: Sector Perform Old Target: GBX 80.00 New Target: GBX 100.00 Upgrade
08/06/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 100.00 New Target: GBX 100.00 Maintain
05/06/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 105.00 New Target: GBX 100.00 Maintain
24/05/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 112.00 New Target: GBX 105.00 Maintain
24/05/2017 Broker: Barclays Capital Rating: Underweight Maintain
23/05/2017 Broker: FinnCap Rating: Buy Old Target: GBX 150.00 New Target: GBX 150.00 Maintain
23/05/2017 Broker: Liberum Capital Rating: Hold Old Target: GBX 90.00 New Target: GBX 90.00 Maintain
10/05/2017 Broker: Shore Capital Rating: Not Rated Maintain
10/05/2017 Broker: Liberum Capital Rating: Hold New Target: GBX 90.00 Downgrade

London: In a note revealed to investors on 21 June, Berenberg Bank reaffirmed their Buy rating on shares of Spire Healthcare Group (LON:SPI). They currently have a GBX 390.00 price target on the firm. Berenberg Bank’s target indicates a potential upside of 15.49% from the company’s last close price.

Spire Healthcare Group plc is a United Kingdom independent hospital group. The company has market cap of 1.35 billion GBP. The Firm provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. It has a 25.28 P/E ratio. The Firm also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

About 123,679 shares traded. Spire Healthcare Group PLC (LON:SPI) has 0.00% since June 21, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 11 analysts covering Spire Healthcare Group (LON:SPI), 6 have Buy rating, 1 Sell and 4 Hold. Therefore 55% are positive. Spire Healthcare Group has GBX 460 highest and GBX 234 lowest target. GBX 364.82’s average target is 8.13% above currents GBX 337.4 stock price. Spire Healthcare Group had 90 analyst reports since July 23, 2015 according to SRatingsIntel. JP Morgan maintained Spire Healthcare Group PLC (LON:SPI) on Monday, November 23 with “Neutral” rating. Investec maintained Spire Healthcare Group PLC (LON:SPI) on Monday, February 1 with “Sell” rating. As per Tuesday, January 17, the company rating was maintained by Liberum Capital. Berenberg maintained the stock with “Buy” rating in Wednesday, August 10 report. On Monday, August 24 the stock rating was maintained by Jefferies with “Buy”. As per Wednesday, January 18, the company rating was maintained by Berenberg. The firm has “Buy” rating by Berenberg given on Tuesday, March 14. Numis Securities maintained the stock with “Add” rating in Monday, April 4 report. The rating was maintained by JP Morgan on Thursday, January 14 with “Neutral”. Numis Securities maintained it with “Add” rating and GBX 360 target in Thursday, March 17 report.

Gem Diamonds Limited is a United Kingdom diamond producer, which is engaged in the exploration and development of diamond mines. The company has market cap of 131.96 million GBP. The Firm operates diamond mining activities in Lesotho and Botswana. It currently has negative earnings. The Company’s geographical divisions include Lesotho, which is involved in diamond mining activities; Botswana, which is engaged in diamond mining activities; Belgium, which is involved in the sales, marketing and manufacturing of diamonds, and British Virgin Islands , Republic of South Africa (RSA) and the United Kingdom, which provides technical and administrative services.

About 3,061 shares traded. Gem Diamonds Limited (LON:GEMD) has 0.00% since June 21, 2016 and is . It has underperformed by 16.70% the S&P500.